key: cord-0732270-t9qgnk73
authors: Aylward, Ryan; Bieber, Brian; Guedes, Murilo; Pisoni, Ronald; Tannor, Elliot Koranteng; Dreyer, Gavin; Liew, Adrian; Luyckx, Valerie; Shah, Dibya Singh; Phiri, Chimota; Evans, Rhys; Albakr, Rehab; Perl, Jeffrey; Jha, Vivekanand; Pecoits-Filho, Roberto; Robinson, Bruce; Caskey, Fergus J.
title: The global impact of the Coronavirus 2019 pandemic on in-centre haemodialysis services: an International Society of Nephrology -Dialysis Outcomes Practice Patterns Study survey.
date: 2021-12-13
journal: Kidney Int Rep
DOI: 10.1016/j.ekir.2021.12.011
sha: d85e933abe2dec492080b9c12bd526c348da99b1
doc_id: 732270
cord_uid: t9qgnk73

INTRODUCTION: To assess the impact of the COVID-19 pandemic impact on haemodialysis centres, The Dialysis Outcomes and Practice Patterns Study and International Society of Nephrology (ISN) collaborated on a web-survey of centres. METHODS: A combined approach of random sampling and open invitation was used between March 2020 and March 2021. Responses were obtained from 412 centres in 78 countries and all 10 ISN regions. RESULTS: In 8 regions, rates of SARS-CoV-2 infection were <20% in most centres, but in North East Asia and Newly Independent States and Russia rates were ≥20% and ≥30%, respectively. Mortality was ≥10% in most centres in 8 regions, though lower in North America and Caribbean and North East Asia. Diagnostic testing was not available in 33%, 37%, and 61% of centres in Latin America, Africa, and East and Central Europe, respectively. Surgical masks were widely available, but severe shortages of particulate-air filter masks were reported in Latin America (18%) and Africa (30%). Rates of infection in staff ranged from 0% in 90% of centres in North East Asia to ≥50% in 63% of centres in the Middle East and 68% of centres in Newly Independent States and Russia. In most centres <10% of staff died, but in Africa and South Asia 2% and 6% of centres reported ≥50% mortality, respectively. CONCLUSION: There has been wide global variation in SARS-CoV-2 infection rates amongst haemodialysis patients and staff, PPE availability, and testing, and the ways in which services have been redesigned in response to the pandemic.

In 8 regions, rates of SARS-CoV-2 infection were <20% in most centres, but in North East Asia and Newly Independent States and Russia rates were ≥20% and ≥30%, respectively.

Mortality was ≥10% in most centres in 8 regions, though lower in North America and Caribbean and North East Asia. Diagnostic testing was not available in 33%, 37%, and 61% of centres in Latin America, Africa, and East and Central Europe, respectively. Surgical masks were widely available, but severe shortages of particulate-air filter masks were reported in Latin America (18%) and Africa (30%). Rates of infection in staff ranged from 0% in 90% of centres in North East Asia to ≥50% in 63% of centres in the Middle East and 68% of centres in Newly Independent States and Russia. In most centres <10% of staff died, but in Africa and South Asia 2% and 6% of centres reported ≥50% mortality, respectively. We leveraged the ISN's network of national nephrology societies and registries to understand the impact of the pandemic on HD centres across the world. We adopted a novel strategy to lessen survey response bias, cultivated over the last 25 years by the Dialysis Outcomes and Practice Pattern Study (DOPPS), (22) to randomly sample centres to provide an understanding of the impact of the COVID-19 pandemic on HD centres and services from frontline providers. The experience of peritoneal dialysis (PD) centres and J o u r n a l P r e -p r o o f comparisons between low-and middle-income (LMIC) and high-income (HIC) countries are explored in companion manuscripts.

[H1] Methods

An initial survey to assess the impact of COVID-19 on dialysis services was developed by DOPPS investigators and administered in May-June 2020 to sites participating in DOPPS phase 7 (HD centres in Gulf Cooperation Council, United States, China, and seven European countries), and PDOPPS (PD centres in Thailand and South Korea). In May 2020, DOPPS and ISN agreed to collaborate in revising and extending the survey to countries not participating in DOPPS. The survey was reviewed by clinicians working in low-and middle-income countries, and questions relevant to these settings added (additional questions) or adapted (additional response options). Pilot testing was then performed by purposively sampled nephrology colleagues working in a range of settings, with an average survey completion time of 30 min for the main questions. After professional translation into French, Russian and Spanish, the survey was deployed in SurveyMonkey (www.surveymonkey.com). The format was specifically designed to be user-friendly and completed on a desktop computer, tablet, or smartphone. Completion was voluntary and no compensation was provided.

[H2] Sampling of countries and invitation of countries and individual dialysis centres

The adapted survey was subsequently disseminated through two additional stages, detailed in the Supplementary Methods. In stage 1, individual centres were selected from a list of centres in that country, provided by ISN member-societies. For countries with > 40 centres nationwide, 20 centres stratified by region and dialysis patient population, were randomly J o u r n a l P r e -p r o o f selected. In stage 2, an open invitation of the survey was advertised via social media. This second stage was added after we noted that responses from many important countries and centres within countries were not received, despite extensive efforts to engage with country and region societies and email reminders.

[H2] Ethics approval The characteristics of responding centres are presented by ISN region in Table 1 . Most centres (79%) were located in an urban area, except in N America & Caribbean where only 29% were in an urban area, with 32% in a sub-urban area and 39% in a rural area. Paediatric services were represented in 30% of responding centres (28% combined with adult services and 2% paediatric only), with this rising to 66% in Africa (63% combined with adult services and 3% paediatric only). Characteristics of the survey respondents are presented in Supplementary Table S1 . Patient mortality was reported to be ≥10% in more than 60% of centres in eight of the 10 ISN regions, the exceptions being North America and North East Asia where mortality was reported to be lower. In Latin America and Africa, 25% and 26% of HD centres reported mortality rates over 50%, respectively. ( Figure 5 ).

[H2] SARS-CoV-2 diagnostic and antibody testing of symptomatic dialysis patients Reporting on the situation in the early months of the pandemic (April and May 2020), diagnostic testing (e.g., polymerase chain reaction, PCR) was only reported to be widely available in SE Asia & Oceania (69% of responding centres) ( Table 2) . Later, at the time of the survey (November 2020 -March 2021), testing had improved, but was still not available in a significant percentage of centres in some regions: Latin America (33%), Africa (37%), and E&C Europe (61%). Access to antibody testing was even more limited (Supplementary   Table S3 ).

Surgical masks were mostly worn for direct contact with all patients, with particulate-air filter respirators being used sparingly (Table 3) . Surgical masks were not available at all in 1% of centres, and there was a severe shortage in 5% and a moderate shortage in 22% (Table 4 ). Access to particulate-air filter masks was even more limited, with a severe shortage reported in 30% of African and 18% of Latin American centres. In all regions, many J o u r n a l P r e -p r o o f [H2] Access to HD and missed visits Transportation to/ from the dialysis centre was reported to be challenging in many or most centres across all regions: Africa (65%), E&C Europe (73%), Latin America (79%), Middle East centres because of cessation of shared transportation services to/ from HD, which was problematic in all regions, disruptions to HD shifts, or fear of being exposed to SARS-CoV-2.8,(11) Shared transportation has been found to be an independent risk factor for infection, (37) but for many patients shared and public transport is the only available means of accessing dialysis.

As part of social distancing recommendations, few centres reported increasing the distance between machines to more than 2m (25% across all regions), whereas most reported achieving 1 -2m (62%). This may have been because adopting a 2m policy would have resulted in a significant reduction in the number of people who could be treated in the same HD centre, and the consequences of that being weighed against the risks of SARS-CoV-2 infection. Further, it has been suggested in general population studies that even a distance 2m may not be enough to prevent SARS-CoV-2 transmission. (38) However, in the HD population, there is some evidence from the UK that every 1m increase in spacing between machines decreases the transmission of SARS-CoV-2 and admission to hospital by 32%. (25) For patients with confirmed SAR-CoV-2 infection, dedicated shifts were used to isolate these patients from others in 65% (N America & Caribbean) -95 % (E&C Europe, and S Asia) of centres. This may have been due to space/ time/ staff limitations in the North America & Caribbean region, or due to a greater ability to find alternative solutions, such as isolation rooms or zones within the same dialysis centre. (7, 25, 37) 

The nephrology workforce under non-pandemic conditions is insufficient in many regions, and is essential to maintain HD services.(39) Some regions reported more than half of their staff being infected with SARS-CoV-2. This is much higher than hospital staff seroprevalence Indonesia (stage 1 of survey invitation). The targeted invitation ensured that a range of frontline HD providers was surveyed, not only overly optimistic or pessimistic respondents keen to forward a particular agenda. Responses were anonymous and cannot be traced back to specific people or centres. Deficiencies in resources were anticipated to be most acute and politically sensitive in low-income countries, and it was recognised that the smaller number of HD centres in these countries could make identification of respondents easier. For these reasons, respondents in low-income countries were assured their data would only be reported at a country level. Importantly, there was no differential missing data patterns for particular survey questions and missing responses were overall low. [H2] Future research

We have identified that some regions may have been particularly affected. We therefore have developed a companion manuscript that explores differences between HIC and LMICs.

The experience of PD centres will also be explored separately. Data are available, on request, for non-low-income countries with >5 responses, to leverage change in practice and policy locally. The nephrology community has highlighted that there is variable access to vaccines and divergent vaccine policies across the world and have vehemently advocated for the prioritisation of at-risk dialysis patients and staff. (46) A survey on the availability and implementation of vaccine rollout programmes is therefore planned.

This collaborative, wide-reaching survey using a novel sampling approach has found that the COVID-19 pandemic has had a significant impact on dialysis services and staffing worldwide. [H1] Acknowledgements

We would like to thank national Society and Registry country and ISN Regional Board leads who provided lists of dialysis centres that we were then able to contact. Supplementary 

The Novel Coronavirus 2019 epidemic and kidneys

COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

COVID-19 and the kidney: A South African state healthcare experience

Role of screening for COVID-19 in hemodialysis wards, results of a single center study

Current status of COVID-19 among hemodialysis patients in the East Azerbaijan Province of Iran

Covid-19 in patients undergoing long-term dialysis in ontario

COVID-19 Outbreak in an Urban Hemodialysis Unit

Epidemiology of COVID-19 in an urban dialysis center

The impact of COVID-19 in hemodialysis patients: Experience in a hospital dialysis unit

COVID-19 in hemodialysis (HD) patients: Report from one HD

Study of covid-19 pandemic in representative dialysis population across mumbai, india: An observational multicentric analysis

Impact of COVID-19 on maintenance haemodialysis patients: The Indian scenario

Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: The observational COVIDIAL study

Going to war with COVID-19: Strategies for SARS-CoV-2 management in the Padua Nephrology and Dialysis Unit's hemodialysis facility

Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion

The International Society of Nephrology COVID-19 Recommendations

Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities

Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres

COVID-19 rapid guideline: dialysis service delivery. NICE Guidelines

Guidelines for the prevention, detection and management of the renal complications of COVID-19 in Africa. African Journal of nephrology Official publication of the African Association of Nephrology

Inpatient dialysis planning during the covid-19 pandemic: A single-center experience and review of the literature

Dialysis outcomes and practice patterns study (DOPPS): Its strengths, limitations, and role in informing practices and policies

Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey

Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19

Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients

SARS-CoV-2 Seropositivity Rates in Patients and Clinical Staff in New York City Dialysis Facilities: Association With the General Population

High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening

COVID-19 and maintenance hemodialysis: a systematic scoping review of practice guidelines

Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team

Managing the COVID-19 pandemic: international comparisons in dialysis patients

Trends and applications of resilience analytics in supply chain modeling: systematic literature review in the context of the COVID-19 pandemic. Environment Systems and Decisions

COVID-19 in Africa: the spread and response

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Decontamination and re-use of surgical masks and respirators during the COVID-19 pandemic

Safely reducing haemodialysis frequency during the COVID-19 pandemic

Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysisdependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial

The keys to control a COVID-19 outbreak in a haemodialysis unit

Two metres or one: what is the evidence for physical distancing in covid-19?

Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network

Aggressive Quarantine Measures Reduce the High Morbidity of COVID-19 in Patients on Maintenance Hemodialysis and Medical Staff of Hemodialysis Facilities in Wuhan

Mass Disasters and Burnout in Nephrology Personnel

AKI treated with renal replacement therapy in critically ill patients with COVID-19

The work environment of haemodialysis nurses and its mediating role in burnout

The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action